Evidence for linkage on 21q and 7q in a subset of autism characterized by developmental regression

Molecular Psychiatry

Volumn 10, Issue 8, 2005, Pages 741-746

  Molloy, C A ^a,b   Keddache, M ^a   Martin, L J ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

AGRE; Autistic disorder; Chromosome 21; Developmental regression

Indexed keywords

ARTICLE; AUTISM; CHROMOSOME 21Q; CHROMOSOME 7Q; DATA BASE; FAMILY; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENOME; GENOTYPE; HUMAN; INHERITANCE; INTERVIEW; LINKAGE ANALYSIS; PRIORITY JOURNAL;

AUTISTIC DISORDER; CHILD; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 7; DEVELOPMENTAL DISABILITIES; FAMILY; FEMALE; GENETIC MARKERS; HUMANS; LOD SCORE; MALE; REGISTRIES;

EID: 23744485061     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001691     Document Type: Article

References (51)

1. American Psychiatric Associaiton. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington, DC, 2000.
2. Folstein SE, Rosen-Sheidley B. Genetics of autism: complex aetiology for a heterogeneous disorder. Nat Rev Genet 2001; 2: 943-955.
3. Lamb JA, Moore J, Bailey A, Monaco AP. Autism: recent molecular genetic advances. Hum Mol Genet 2000; 9: 861-868.
4. Auranen M, Vanhala R, Varilo T, Ayers K, Kempas E, Ylisaukko-Oja T et al. A genomewide screen for autism-spectrum disorders: evidence for a major susceptibility locus on chromosome 3q25-27. Am J Hum Genet 2002; 71: 777-790.
5. Gutknecht L. Full-genome scans with autistic disorder: a review. Behav Genet 2001; 31: 113-123.
6. IMGSAC, T.I.M.G.S.o.A.C. A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am J Hum Genet 2001; 69: 570-581.
7. Liu J, Nyholt DR, Magnussen P, Parano E, Pavone P, Geschwind D et al. A genomewide screen for autism susceptibility loci. Am J Hum Genet 2001; 69: 327-340.
8. Philippe A, Martinez M, Guilloud-Bataille M, Gillberg C, Rastam M, Sponheim E et al. Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study. Hum Mol Genet 1999; 8: 805-812.
9. Risch N, Spiker D, Lotspeich L, Nouri N, Hinds D, Hallmayer J et al. A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet 1999; 65: 493-507.
10. Yonan AL, Alarcon M, Cheng R, Magnusson PK, Spence SJ, Palmer AA et al. A genomewide screen of 345 families for autism-susceptibility loci. Am J Hum Genet 2003; 73: 886-897.
11. Silverman JM, Smith CJ, Schmeidler J, Hollander E, Lawlor BA, Fitzgerald M et al. Symptom domains in autism and related conditions: evidence for familiality. Am J Med Genet 2002; 114: 64-73.
12. Lord C, Pickles A, McLennan J, Rutter M, Bregman J, Folstein S et al. Diagnosing autism: analyses of data from the Autism Diagnostic Interview. J Autism Dev Disord 1997; 27: 501-517.
13. Lord C, Risi S, Lambrecht L, Cook Jr EH, Leventhal BL, DiLavore PC et al. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 2000; 30: 205-223.
14. Shao Y, Raiford KL, Wolpert CM, Cope HA, Ravan SA, Ashley-Koch AA et al. Phenotypic homogeneity provides increased support for linkage on chromosome 2 in autistic disorder. Am J Hum Genet 2002; 70: 1058-1061.
15. Buxbaum JD, Silverman J, Keddache M, Smith CJ, Hollander E, Ramoz N et al. Linkage analysis for autism in a subset families with obsessive-compulsive behaviors: evidence for an autism susceptibility gene on chromosome 1 and further support for susceptibility genes on chromosome 6 and 19. Mol Psychiatry 2004; 9: 144-150.
16. Molloy C, Morrow A, Meinzen-Derr J, Dawson G, Bernier R, Dunn M et al. Familial autoimmune thyroid disease as a risk factor for regression in children with autism spectrum disorder: A CPEA study. J Aut Dev Disord 2005, in press.
17. Goldberg W, Osann K, Filipek P, Laulhere T, Jarvis K, Modahl C et al. Language and other regression: assessment and timing. J Aut Dev Disord 2003; 33: 607-616.
18. Lord C, Shulman C, DiLavore P. Regression and word loss in autistic spectrum disorders. J Child Psychol Psychiatry 2004; 45: 936-955.
19. Burack JA, Volkmar FR. Development of low- and high-functioning autistic children. J Child Psychol Psychiatry 1992; 33: 607-616.
20. Kobayashi R, Murata T. Setback phenomenon in autism and long-term prognosis. Acta Psychiatr Scand 1998; 98: 296-303.
21. Brown J, Prelock PA. Brief report: the impact of regression on language development in autism. J Autism Dev Disord 1995; 25: 305-309.
22. Siperstein R, Volkmar F. Parental reporting of regression in autism. J Aut Dev Disord 2004; 34: 731-734.
23. Geschwind DH, Sowinski J, Lord C, Iversen P, Shestack J, Jones P et al. The autism genetic resource exchange: a resource for the study of autism and related neuropsychiatric conditions. Am J Hum Genet 2001; 69: 463-466.
24. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996; 58: 1347-1363.
25. Greenberg DA, Abreu P, Hodge SE. The power to detect linkage in complex disease by means of simple LOD-score analyses. Am J Hum Genet 1998; 63: 870-879.
26. Sham P. Statistics in Human Genetics. John Wiley & Sons: New York, 1998.
27. Broman KW, Murray JC, Sheffield VC, White RL, Weber JL. Comprehensive human genetic maps: individual and sex-specific variation in recombination. Am J Hum Genet 1998; 63: 861-869.
28. Terwilliger JD, Speer M, Ott J. Chromosome-based method for rapid computer simulation in human genetic linkage analysis. Genet Epidemiol 1993; 10: 217-224.
29. Terwilliger JD, Ott J. Handbook of Human Genetic Linkage. Johns Hopkins University Press: Baltimore, 1994.
30. Abreu PC, Greenberg DA, Hodge SE. Direct power comparisons between simple LOD scores and NPL scores for linkage analysis in complex diseases. Am J Hum Genet 1999; 65: 847-857.
31. Barrett S, Beck JC, Bernier R, Bisson E, Braun TA, Casavant TL et al. An autosomal genomic screen for autism. Collaborative linkage study of autism. Am J Med Genet 1999; 88: 609-615.
32. Shao Y, Wolpert CM, Raiford KL, Menold MM, Donnelly SL, Ravan SA et al. Genomic screen and follow-up analysis for autistic disorder. Am J Med Genet 2002; 114: 99-105.
33. Tomko RP, Johansson CB, Totrov M, Abagyan R, Frisen J, Philipson L. Expression of the adenovirus receptor and its interaction with the fiber knob. Exp Cell Res 2000; 255: 47-55.
34. Yoshida Y, Matsuda S, Ikematsu N, Kawamura-Tsuzuku J, Inazawa J, Umemori H et al. ANA, a novel member of Tob/BTG1 family, is expressed in the ventricular zone of the developing central nervous system. Oncogene 1998; 16: 2687-2693.
35. Guehenneux F, Duret L, Callanan MB, Bouhas R, Hayette S, Berthet C et al. Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle. Leukemia 1997; 11: 370-375.
36. Corrente G, Guardavaccaro D, Tirone F. PC3 potentiates NGF-induced differentiation and protects neurons from apoptosis. Neuroreport 2002; 13: 417-422.
37. Fatemi S, Stary JM, Halt AR, Realmuto GR. Dysregulation of Reelin and Bcl-2 proteins in autistic cerebellum. J Autism Dev Disord 2001; 31: 529-535.
38. Araghi-Niknam M, Fatemi SH. Levels of Bcl-2 and P53 are altered in superior frontal and cerebellar cortices of autistic subjects. Cell Mol Neurobiol 2003; 23: 945-952.
39. Levitt P, Eagleson KL, Powell EM. Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders. Trends Neurosci 2004; 27: 400-406.
40. James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 2004; 80: 1611-1617.
41. Chauhan A, Chauhan V, Brown WT, Cohen I. Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin-the antioxidant proteins. Life Sci 2004; 75: 2539-2549.
42. Bergelson JM. Receptors mediating adenovirus attachment and internalization. Biochem Pharmacol 1999; 57: 975-979.
43. Chess S. Follow-up report on autism in congenital rubella. J Autism Child Schizophr 1977; 7: 69-81.
44. Shi L, Fatemi SH, Sidwell RW, Patterson PH. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 2003; 23: 297-302.
45. Fatemi SH, Earle J, Kanodia R, Kist D, Emamian ES, Patterson PH et al. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol 2002; 22: 25-33.
46. Alenius M, Bohm S. Identification of a novel neural cell adhesion molecule-related gene with a potential role in selective axonal projection. J Biol Chem 1997; 272: 26083-26086.
47. Paoloni-Giacobino A, Chen H, Antonarakis SE. Cloning of a novel human neural cell adhesion molecule gene (NCAM2) that maps to chromosome region 21q21 and is potentially involved in Down syndrome. Genomics 1997; 43: 43-51.
48. Bailey A, Luthert P, Dean A, Harding B, Janota I, Montgomery M et al. A clinicopathological study of autism. Brain 1998; 121(Part 5): 889-905.
49. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003; 100: 9440-9445.
50. Kent L, Evans J, Paul M, Sharp M. Comorbidity of autistic spectrum disorders in children with Down syndrome. Dev Med Child Neurol 1999; 41: 153-158.
51. Hickey FJ, Patterson B. Occurrence of language regression and EEG abnormalities in children with Down syndrome and autism spectrum disorder. Presented at the International Meeting for Autism Research, May 5-7, 2005, Boston.